Quarterly report pursuant to Section 13 or 15(d)

Reconciliation of IFRS Disclosure to US GAAP Disclosure (Details) - Schedule of shareholders' equity

v3.21.2
Reconciliation of IFRS Disclosure to US GAAP Disclosure (Details) - Schedule of shareholders' equity - USD ($)
May 31, 2019
Aug. 31, 2018
Schedule of shareholders' equity [Abstract]    
Total shareholders’ equity in accordance with IFRS $ 46,193,400 $ 32,929,400
Components of share capital in accordance with IFRS    
Share capital 100,109,913 77,870,606
Shares to be issued 1,068,000 996,401
Share option reserve 14,485,974 12,823,000
Share warrant reserve 6,246,032 3,207,915
Total Components of share capital in accordance with IFRS 121,909,919 94,897,922
Adjustment for:    
Share-based compensation (217,862) 528,874
Total share capital in accordance with US GAAP 121,692,057 95,426,796
Accumulated deficit in accordance with IFRS (75,716,519) (61,968,522)
Adjustment for:    
Share-based compensation 217,862
Debt issue costs (51,894) (528,874)
Accumulated deficit in accordance with US GAAP (75,550,551) (62,497,396)
Shareholders equity in accordance with US GAAP $ 46,141,506 $ 32,929,400